Metadata
- Name
- huCART19-IL18 in NHL/CLL Patients
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04684563
- Description
- The purpose of this study is to find the maximum dose of huCART19-IL18 cells that is safe for
use in humans with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). - Data or Study Types
- clinical trial
- Keywords
- CLL, NHL, CAR-T cells
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2020
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04684563
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04684563